{"nct_id":"NCT02736955","title":"Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2016-06-13","start_date_type":"ACTUAL","primary_completion_date":"2017-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-06-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NBIX"]}